Background: Body size is associated with increased brachial systolic blood pressure (SBP) and aortic stiffness. The aims of this study were to determine the relationships between central SBP and body size (determined by body mass index (BMI), waist circumference and waist/hip ratio) in health and disease. We also sought to determine if aortic stiffness was correlated with body size, independent of BP. Methods: BMI, brachial BP and estimated central SBP (by SphygmoCor and radial P2) were recorded in controls (n ¼ 228), patients with diabetes (n ¼ 211), coronary artery disease (n ¼ 184) and end-stage kidney disease (n ¼ 68). Additional measures of waist circumference and arterial stiffness (aortic and brachial pulse wave velocity (PWV)) were recorded in a subgroup of 75 controls (aged 51 ± 12 years) who were carefully screened for factors affecting vascular function. Results. BMI was associated with brachial (r ¼ 0.30; Po0.001) and central SBP (r ¼ 0.29; Po0.001) in the 228 controls, but not the patient populations (ro0.13; P40.15 for all comparisons). In the control subgroup, waist circumference was also significantly correlated with brachial SBP (r ¼ 0.29; P ¼ 0.01), but not central SBP (r ¼ 0.22; P ¼ 0.07). Independent predictors of aortic PWV in the control subgroup were brachial SBP (b ¼ 0.43; Po0.001), age (b ¼ 0.37; Po0.001), waist circumference (b ¼ 0.39; P ¼ 0.02) and female sex (b ¼ À0.24; P ¼ 0.03), but not BMI. Conclusion. In health, there are parallel increases in central and brachial SBP as BMI increases, but these relationships are not observed in the presence of chronic disease. Moreover, BP is a stronger correlate of arterial stiffness than body size.
Introduction
Although it is accepted that high brachial blood pressure (BP) is a major risk factor for cardiovascular disease, recent studies have shown that central BP, as well as indices from the central arterial pressure waveform (for example, augmentation index) may be of more relevance when assessing the association between BP and cardiovascular risk. 1 The additional prognostic value of central BP is likely because of large variations in central systolic BP (SBP; that is 430 mm Hg) between individuals with similar brachial SBP. Previous studies have shown that increases in body mass index (BMI) are positively correlated with brachial SBP 2 and this association may help to explain the additional cardiovascular risk conferred to individuals who carry excess body size. However, the individual variation in central SBP among people with similar brachial SBP raises the possibility that there may be a differential association between central SBP and BMI. Therefore, the first aim of this study was to assess the relationships of central and brachial SBP with BMI in healthy individuals. Recent studies have shown that the normal centralto-brachial BP relationship is altered in the presence of cardiovascular risk factors (such as hypertension, hypercholesterolaemia and smoking) or diabetes and cardiovascular disease. 3, 4 This altered central-to-brachial BP relationship is likely to be due to numerous factors including vascular irregularities (for example, increased large artery stiffness) or autonomic dysfunction (for example, increased heart rate) and this would be expected to more profoundly affect central compared with brachial BP. 5 To our knowledge the relationships of central and brachial SBP with BMI has never been assessed in people with existing disease (that is type 2 diabetes, coronary artery disease or end-stage kidney disease (ESKD)), which was an additional aim of this study. We hypothesised that the presence of disease would change the association between SBP and BMI. Independent of brachial BP, large artery stiffness (for example, aortic pulse wave velocity, (PWV)) predicts cardiovascular outcomes in specific patient groups as well as the general population. 6 Some investigators have reported a positive association between large artery stiffness and measures of obesity. 7, 8 However, this relationship may be confounded by the concomitant association between BP and obesity, as large artery stiffness is correlated with BP. 9 Therefore, the second aim of this study was to determine if measures of large artery stiffness (aortic and brachial PWV) were significantly correlated with body size, independent of BP. We hypothesised that BP would be a stronger determinant of arterial stiffness than body size. Contrary to other work in the field 8,10,11 we were interested in studying a cohort of healthy individuals, carefully screened for factors known to affect vascular function, including coronary artery or vascular disease, treated hypertension, chronic kidney disease, dyslipidaemia or hyperglycaemia. Table 1 .
Materials and methods

Study population
Anthropometry
BMI is an estimation of body size that is widely used to diagnose obesity and predicts mortality, 12 but has poor sensitivity for calculating percentage body fat. 13 Waist circumference, on the other hand, is highly correlated with intra-abdominal fat volumes determined by magnetic resonance imaging, 14 and predicts increased mortality beyond that accounted for by BMI. 15 BMI was calculated by dividing weight in kilograms by the square of height in metres. Waist Central blood pressure and body size OO Kolade et al circumferences were measured at the obvious narrowing between the lower rib and the iliac crest. If there was no obvious narrowing then mid distance between the two landmarks was used. Hip circumferences were measured at the level of the greater posterior protuberance. 16 Brachial BP The average of two consecutive brachial BP readings, measured by mercury sphygmomanometer after at least 5 min rest in the supine position, was recorded.
Central BP Supine pressure waveforms were acquired by radial applanation tonometry using a hand held tonometer (SPC-301, Millar Instruments, TX, USA) and central BP was estimated using a generalised transfer function and customised software (SphygmoCor 8.0, AtCor Medical, Sydney, New South Wales, Australia). The brachial SBP and diastolic BP measurements, taken within 1 to 2 min of waveform acquisition, were used to calibrate the radial pressure waveform. In addition to the use of a generalised transfer function, central SBP was also estimated from the second systolic peak on the radial waveform (radial P2). 17 Mean arterial pressure was determined by integration of the radial pressure waveform. Pulse pressure amplification was defined as the ratio of brachial to central pulse pressure.
Arterial stiffness
Supine aortic and brachial PWV were determined by electrocardiogram gated sequential recording of pressure waveforms at two sites (SphygmoCor 8.0, AtCor Medical), the carotid and femoral arteries for aortic PWV, and the carotid and radial arteries for brachial PWV. The average of two PWV readings at each site was taken for analysis. Aortic pulse wave timing (T R ) was measured from the central pressure waveform as surrogate marker of aortic PWV. 9 The central AIx was measured as a surrogate index of systemic arterial stiffness, defined as the difference between the first and second peaks of the synthesised central arterial waveform, expressed as a percentage of the pulse pressure. This variable is dependent on heart rate, and was also corrected to a heart rate of 75 bpm. The radial AIx was defined as the ratio of the amplitude of the second systolic peak to the amplitude of the first systolic peak of the radial arterial waveform.
Blood biochemistry
Blood samples were obtained by venipuncture at the antecubital fossa after an overnight fast. Standard blood lipid, glucose and insulin assays were performed by Hospital Pathology Departments for all blood biochemistry.
Statistical analysis
Data are presented as means ± s.d. and Po0.05 was considered significant. Associations between variables were assessed using Pearson correlations or partial correlations when correcting for potentially confounding variables.
Comparison of the slope of the regression line between groups was assessed by the Z statistic. Sex differences were assessed by independent t-tests. Differences between patient populations and across tertiles were analysed by one-way ANOVA and Bonferroni was used as the post-hoc test. Backward linear regression was used to determine predictors of arterial stiffness. Multicollinearity was determined by tolerance o0.10 and a variance inflation factor 410. Furthermore, if independent variables were highly correlated (rX0.70), they were separately added to the regression model. Thus, BMI, waist and hip (r40.70) were not included in the same model, however, BMI and waist/hip ratio (ro0.40) were in the same model. Analyses were performed using SPSS software, version 16.0 (SPSS Inc., Chicago, IL, USA).
Results
All patients: body size and BP relationships As shown in Table 1 , the 228 healthy controls were generally younger with lower BMI, brachial and central BP's compared with the other patient populations. There were significant associations between BMI and both brachial as well as central SBP in the healthy controls (Table 2 and Figure 1) . Furthermore, the correlation between radial P2 (estimated central SBP without a transfer function) and BMI was also Central blood pressure and body size OO Kolade et al significant (r ¼ 0.28; Po0.001) in the controls. In contrast, there were no significant associations between BMI and brachial or central SBP in all other patient populations. Indeed, the slopes of the correlation coefficients for the BMI/ SBP relationships in the controls were significantly different from all patient groups ( Table 2 ). The pattern of associations between BMI and BP were not significantly changed after correction for age and heart rate. Specifically, for the healthy controls, there were still significant relationships between BMI and brachial SBP (r ¼ 0.25; Po0.001) as well as central SBP (r ¼ 0.23; Po0.001). However, there were no significant associations between BMI and brachial or central SBP in the patient groups (rp0.12 and PX0.31 for all). BMI was not significantly correlated with pulse pressure amplification or the aortic to brachial SBP difference (brachial SBP-central SBP) in the controls or patients with ESKD (ro0.15; P40.23 for all). However, for patients with type 2 diabetes, there were small but significant associations between BMI and pulse pressure amplification (r ¼ 0.21; P ¼ 0.002), as well as aortic to brachial SBP difference (r ¼ 0.16; P ¼ 0.02). Similar correlations were observed in the patients with known or suspected coronary artery disease (r ¼ 0.25; P ¼ 0.001 and r ¼ 0.17; P ¼ 0.02, respectively).
Control subgroup: body size and BP relationships Characteristics of the control subgroup are shown in Table 3 . Males had greater waist and waist/hip ratio but lower central pulse pressure and augmentation index (central and radial) compared with women. As per the larger control group, BMI was significantly associated with brachial and central SBP (r ¼ 0.37; P ¼ 0.001 for both) as well as radial P2 (r ¼ 0.35; P ¼ 0.002). Conversely, there were no significant correlations between waist/hip ratio and brachial SBP (r ¼ 0.19; P ¼ 0. Control subgroup: body size, BP and arterial stiffness relationships Table 4 summarises correlations between measures of arterial stiffness and body size. Only aortic PWV was positively correlated with measures of body size, whereas central augmentation index was negatively associated with waist/ hip ratio. There was a significant increase in aortic PWV (Po0.05) but not brachial PWV (P ¼ 0.07) across tertiles of BMI but there was no significant change in either PWV measure across tertiles of waist circumference (P40.18 for both). Aortic PWV was correlated with brachial SBP (r ¼ 0.55; Po0.001) and the association remained significant after correction for BMI or waist circumference (r ¼ 0.51; Po0.001). On the other hand, although aortic PWV was correlated with both BMI and waist circumference (Table 4) , after correcting for brachial SBP, the relationship between these variables were no longer significant (r ¼ 0.04; P ¼ 0.73 and r ¼ 0.16; P ¼ 0.20, respectively).
Multiple regression for predictors of arterial stiffness
Variables suspected to contribute to the variance in arterial stiffness (including all body size variables), or those variables 
Discussion
The novel findings of this study are, firstly, that estimated central SBP followed the same pattern of positive association with BMI as brachial SBP in healthy individuals, but this was not observed in patients with pre-existing coronary artery disease, or those with increased cardiovascular risk (type 2 diabetes mellitus or ESKD). Secondly, in carefully screened healthy individuals, when BMI was replaced with waist circumference as a measure of body size, there was a differential association between brachial SBP (significant relationship) and central SBP (nonsignificant relationship). Finally, our data in healthy individuals show that BP is a stronger correlate of arterial stiffness than body size.
Central BP and body size
Studies have demonstrated that brachial SBP increases in concert with BMI, 2 thereby partly apportioning the rise in BP to increased cardiovascular risk from weight gain. Our findings of a concomitant rise in both brachial and central SBP support this theory in the healthy cohort, but not in the patients with known disease. Although complete information on the use of drugs that affect the vasculature such as statins and antihypertensive agents in the patient populations were not available, the use of such agents was likely to be an influencing factor regarding the lack of association with BMI and brachial or central SBP, particularly as BP lowering agents may be used prophylactically in the absence of high BP in patients with diabetes, coronary artery disease and kidney disease. Alternatively, increased large artery stiffness and impaired endothelial function are features common to the patient groups in this current study and, although this may impact on both brachial and central SBP, these vascular irregularities may have more of an influence on the amplitude of the second systolic peak on the central waveform (that is increased central BP) compared with brachial BP. On the other hand, autonomic dysfunction and increased heart rates are associated with obesity (possibly related to hyperinsulinaemia), 18 as well as diabetes, 19, 20 kidney disease 21 and coronary artery disease.
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Higher heart rates have been demonstrated to influence the central-to-brachial SBP relationship, such that SBP amplification increases almost exclusively due to elevated brachial SBP, with no significant change to central SBP. 23 Thus, heart rate differences between groups may be another reason for the lack of linear associations between BMI and either brachial or central SBP in the patient populations. Having said this, correction for heart rate (and age) did not alter the relationships between BMI and brachial or central BP in patients or controls. To our knowledge, only one previous study has reported associations between measures of body size and fatness with central haemodynamics estimated by radial tonometry in apparently healthy subjects. 24 These investigators showed that both central and brachial pulse pressure significantly increased across tertiles of BMI as well as tertiles of body fat (as a proportion of total body mass) assessed by bioelectrical impedance. Although these data are in alignment with our own, no objective measures of blood biochemistry or clinical characteristics (apart from BP) were presented and the different methods to assess body size (waist circumference compared with body fat by bio-impedance) 24 make it difficult to directly compare findings. In an indigenous Australian population with and without type 2 diabetes, Maple-Brown et al. 25 noted that several indices of obesity (that is BMI, waist and body weight) were inversely associated with AIx. Another study of older individuals This observation may be a clue to the mechanisms underlying the attenuation of AIx as body size increases, as a more compliant artery will act to buffer pressure pulsations and result in a reduced AIx. Perhaps more important are the observations of impaired heart rate variability, increased heart rate, cardiac output and peripheral vasodilation in overweight individuals that are apparently healthy, normotensive and normoglycemic. 18, 28 This 'high-output, low-resistance' haemodynamic milieu will reasonably be expected to result in significantly lower central SBP compared with peripheral SBP (increased SBP amplification), and thereby potentially help explain the differential relationships between body size and central versus peripheral BP. 23, 29 Further studies are needed to understand the relation between body size and central BP.
Body size and arterial stiffness
In older adults aortic PWV follows a positive relationship with abdominal visceral fat (measured by computed tomography), and this occurs independently from age or brachial BP. 11 Similar independent associations between aortic PWV and waist circumference 10 as well as other anthropometric measures of body size (for example BMI, hip circumference and waist/hip ratio) have been reported. 8 Ferreira et al. 30 also
showed that higher abdominal fat mass adversely correlated with carotid to femoral PWV. Our own data are in accordance with the above studies, with the additional observation that BP remains the most significant predictor of aortic stiffness. Indeed, after correcting for brachial SBP the relationships between aortic PWV and body size measures (BMI and waist circumference) were no longer significant. This is perhaps not unexpected given the strong relationship between BP and arterial stiffness, 31 thought to be due to extra recruitment of collagen fibres to help 'stiffen' large arteries against increased distending pressure. 32 Nonetheless, body fat distribution does appear to have independent vascular effects. Although this current study cannot assign a mechanism to explain this, some possible contributing factors present in the setting of obesity include systemic inflammation, 33 increased leptin, 34 dyslipidaemia, 35 hyperinsulinaemia or hyperglycaemia.
36
Limitations This is a cross-sectional study with a low prevalence of severe obesity. We have also used basic methods to estimate body fatness and future studies using more sensitive techniques to assess fat distribution may return different findings. Furthermore, estimation of the carotid to femoral PWV was carried out by measuring tape in a direct line from the sternal notch to the femoral artery and this traverses the abdomen. This method may introduce a systematic error in which carotid to femoral PWV (and PWV) is progressively overestimated as waist size increases, thereby potentially creating an erroneous association between aortic PWV and waist circumference. The use of calipers to estimate the pulse transit distance would overcome this potential problem. Many participants in the clinical groups would have been taking medication, which may have altered the central-to-brachial BP relationship, and a more comprehensive medication history would have clarified this possibility. However, none of the healthy subjects were taking vasoactive medications.
Conclusions
The main finding of this study was that brachial SBP and estimated central SBP are similarly correlated with BMI in healthy individuals, but not those with established vascular disease (related to diabetes, coronary artery disease or ESKD).
As central haemodynamics predict target organ damage and cardiovascular outcome, 1 these data provide further insight as to the risk conferred by central BP in response to weight gain. Conversely, we also found a lack of association between waist circumference (a better measure of abdominal obesity than BMI) and central SBP, suggesting that body fat distribution may influence the magnitude of pulse pressure amplification. Taken together, the findings highlight that in overweight individuals in particular, the true risk related to BP may be more apparent from tonometric central BP estimations than brachial BP.
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